Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Stealing fire: a retrospective survey of biotech patent claims in the wake of Mayo v. Prometheus

Nature Biotechnology volume 30, pages 758–760 (2012)Cite this article

Subjects

The Prometheus decision could have dramatic and long-lasting effects on the protection of biotech-related inventions, especially in the areas of diagnostics, biomarkers and personalized medicine.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Categorization of claims in Class 435 patents according to pre-solution and post-solution activity.

References

  1. Mayo Collaborative Services v. Prometheus Laboratories, Inc., 132 S.Ct. 1289, 566 US __ (March 20, 2012).

  2. Fox, J.L. Nat. Biotechnol. 30, 373–374 (2012).

    Article  CAS  Google Scholar 

  3. O'Reilly v. Morse, 56 US 62 (1854).

  4. Prometheus, 132 S.Ct. at 1298.

  5. Id. at 1298–1300.

  6. 35 USC §154.

  7. Goldstein, J.A. & Bouchez, C.M. Intellect. Prop. Today 18, 18–20 (2011).

    Google Scholar 

  8. Akamai Techs., Inc. v. Limelight Networks, Inc., 629 F.3d 1311 (Fed. Cir. 2010), reh'g en banc granted, No. 2009–1372 (Fed. Cir. Apr. 20, 2011).

  9. McKesson Techs., Inc. v. Epic Sys. Corp., No. 2010–1291 (Fed. Cir. Apr. 12, 2011), reh'g en banc granted, (Fed. Cir. May 26, 2011).

  10. Diamond v. Diehr, 450 US 175 (1981).

  11. Parker v. Flook, 437 US 584 (1978).

  12. 35 USC §120.

  13. 35 USC §251.

  14. 37 CFR §1.175.

  15. Sterne, R.G. et al. US reexamination and reissue practice 2011, Sedona Patent Litigation Conference 2011, Conference Proceedings (The Sedona Conference, Sedona, AZ). http://www.thesedonaconference.com/

  16. Assn. for Molecular Pathology et al. v. Myriad Genetics, et al. 653 F.3d 1329 (Fed. Cir. 2011), vacated [on other grounds], 132 S.Ct. 1289 (2012).

  17. US Patent and Trademark Office. 2012 Interim Procedure for Subject Matter Eligibility Analysis of Process Claims Involving Laws of Nature, July 3, 2012. http://www.uspto.gov/patents/law/exam/2012_interim_guidance.pdf

Download references

Acknowledgements

The authors thank M. Gaszner and P. Khanduri for research assistance, discussion and support, and thank J. Goldstein for a critical review of the manuscript. The views expressed herein are solely those of the authors and do not represent the views of their law firm or of any of its clients. This paper does not constitute legal advice, which can only be given by taking into account individual issues affecting individual clients.

Author information

Authors and Affiliations

  1. Elizabeth J. Haanes and Jaume M. Cànaves are at Sterne, Kessler, Goldstein & Fox, PLLC, Washington, DC, USA.,

    Elizabeth J Haanes & Jaume M Cànaves

Authors
  1. Elizabeth J Haanes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaume M Cànaves
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth J Haanes.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–4, Supplementary Tables 1–4 and Supplementary Methods (PDF 339 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haanes, E., Cànaves, J. Stealing fire: a retrospective survey of biotech patent claims in the wake of Mayo v. Prometheus. Nat Biotechnol 30, 758–760 (2012). https://doi.org/10.1038/nbt.2318

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2318

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research